S
GLSI icon

SignatureFD’s Greenwich LifeSciences GLSI Stock Holding History

SignatureFD’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-251
Closed -$6K – 3202
2021
Q4 		$6K Sell
251
-305
-55% -$10.2K ﹤0.01% 2333
2021
Q3 		$22K Hold
556
– – ﹤0.01% 1714
2021
Q2 		$25K Hold
556
– – ﹤0.01% 1627
2021
Q1 		$19K Hold
556
– – ﹤0.01% 1590
2020
Q4 		$20K Buy
+556
New +$8.11K ﹤0.01% 1444

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SignatureFD's GLSI Position: Q1 2022 in Review

SignatureFD sold out of Greenwich LifeSciences (GLSI) in Q1 2022, closing a stake of 251 shares — an estimated $6K sold.

SignatureFD first reported a position in GLSI in Q4 2020 and held it in 5 quarters. The position peaked at $25K in Q2 2021. 34 funds tracked by Wall St. Rank hold GLSI as of Q1 2022.

  • SignatureFD reported no remaining Greenwich LifeSciences position as of Q1 2022 after selling out during the quarter.
  • SignatureFD sold 251 Greenwich LifeSciences shares in Q1 2022, an estimated $6K.
  • SignatureFD first reported a position in Greenwich LifeSciences in Q4 2020 and held it in 5 quarters.
  • SignatureFD's Greenwich LifeSciences position peaked at $25K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2022.

Based on SignatureFD's 13F filing for Q1 2022, filed 2 May 2022.